Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

DICER1-Mutated Botryoid Fibroepithelial Polyp of the Parotid Duct: Report of the First Case (2021) Erber R, Preidl R, Stöhr R, Haller F, Hartmann A, Kesting MR, Agaimy A Journal article Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort (2021) Weyerer V, Stöhr R, Bertz S, Lange F, Geppert CI, Wach S, Taubert H, et al. Journal article Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients (2021) Eckstein M, Lieb V, Jung R, Sikic D, Weigelt K, Stöhr R, Geppert CI, et al. Journal article High androgen receptor mrna expression is associated with improved outcome in patients with high-risk non-muscle-invasive bladder cancer (2021) Sikic D, Taubert H, Wirtz RM, Breyer J, Eckstein M, Weyerer V, Kubon J, et al. Journal article Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question! (2021) Ohashi R, Hartmann A, Martignoni G, Moch H Journal article Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists (2021) Lang-Schwarz C, Melcher B, Hartmann A, Bertz S, Dregelies T, Lang-Schwarz K, Vieth M, Sterlacci W Journal article miRNA expression characterizes histological subtypes and metastasis in penile squamous cell carcinoma (2021) Hiresh A, Heinzelmann J, Hoelters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Heinzelbecker J, et al. Conference contribution Tumor budding correlates with discohesive growth pattern, tumor invasiveness and is associated with worse survival of pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC) (2021) Eckstein M, Kimmel C, Bruendl J, Weber F, Denzinger S, Gierth M, Burger M, et al. Conference contribution Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling (2021) Wullweber A, Strick R, Lange F, Sikic D, Taubert H, Wach S, Wullich B, et al. Conference contribution Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration (2021) Hecht M, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Klautke G, Laban S, et al. Conference contribution